2016
DOI: 10.1097/dss.0000000000000562
|View full text |Cite
|
Sign up to set email alerts
|

Resistant and Recurrent Late Reaction to Hyaluronic Acid–Based Gel

Abstract: The incidence of late reactions to HA-based fillers varies between products. The authors are reporting an exceptionally high rate of cutaneous reactions for this newly introduced filler. In the authors' experience, broad-spectrum antibiotics in conjunction with repeated high-dose hyaluronidase injections into the inflammatory nodules were effective treatments.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
95
1
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 89 publications
(102 citation statements)
references
References 27 publications
(28 reference statements)
5
95
1
1
Order By: Relevance
“…The main deficiency was that some of the studies did not report those kinds of AEs although they are expected with filler injections . Only one study describes (in 4.25% of patients) prolonged (up to 11 months) and recurrent (average: 3.17 episodes) late (average onset: 8.41 weeks after injection) inflammatory cutaneous reactions, but the incidence might vary between different products. The authors also believe that the prevalence of such reactions is higher and influenced by several parameters including the number and volume of HA‐based gel injections, the nature of the product injected as well as possible individual factors …”
Section: Resultsmentioning
confidence: 99%
“…The main deficiency was that some of the studies did not report those kinds of AEs although they are expected with filler injections . Only one study describes (in 4.25% of patients) prolonged (up to 11 months) and recurrent (average: 3.17 episodes) late (average onset: 8.41 weeks after injection) inflammatory cutaneous reactions, but the incidence might vary between different products. The authors also believe that the prevalence of such reactions is higher and influenced by several parameters including the number and volume of HA‐based gel injections, the nature of the product injected as well as possible individual factors …”
Section: Resultsmentioning
confidence: 99%
“…Although severe adverse events may occur with any HA filler, the rates seem to vary among different products. 22 The fillers cited in this report are characterized as nonimmunogenic, biocompatible, and nontoxic implants, composed of sodium hyaluronate from nonanimal origin cross-linked with 1,4-butanediol diglycidyl ether. 33 37 The technology of the cross-linking varies among different manufacturers.…”
Section: Discussionmentioning
confidence: 99%
“…5 , 18 , 19 , 23 , 37 , 40 However, as the manufacturing procedures remain confidential, one can only speculate on the technology-related factors associated with filler complications. 22 …”
Section: Discussionmentioning
confidence: 99%
“…As most patients treated are healthy people looking for a cosmetic improvement, the treatments performed should be as safe as possible. Although these fillers are known for a reliable safety profile, adverse events do occur . Complications can be caused by the product itself (too strong cross‐linking of the product), the product‐host interaction (allergic reactions, inflammatory responses), or the injection technique performed (accumulation or dislocation of the product due to muscle movement, intravascular injection, or vascular compression of filler material) .…”
Section: Introductionmentioning
confidence: 99%